Peter Joseph Leary MD PhD
Pulmonary Vascular Medicine
Professor of Medicine and Epidemiology (Adjunct) at the University of Washington
Join to View Full Profile
1959 Ne Pacific StSeattle, WA 98195
Phone+1 206-598-4615
Fax+1 206-598-3036
Dr. Leary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Peter Leary is the Director of the Pulmonary Vascular Disease Program at the University of Washington, a board-certified pulmonologist, and a Professor of Medicine and Epidemiology. His grant funded research program is focused on identifying and targeting mechanisms that contribute to pulmonary hypertension and heart failure.
Education & Training
University of Washington School of Public HealthPhD, Epidemiology, 2013 - 2018- University of Washington School of Public HealthMS, Epidemiology , 2010 - 2013
University of WashingtonFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2009- Johns Hopkins University School of MedicineClass of 2005
Certifications & Licensure
WA State Medical License 2009 - 2026
American Board of Internal Medicine Pulmonary Disease
National Board of Physicians and Surgeons Critical Care Medicine- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Pulmonary Disease
Clinical Trials
- Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
- OPsumit USers Registry Start of enrollment: 2014 Apr 30
- U.S. CTEPH Registry Start of enrollment: 2015 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Integrative Multiomics for Prognostic Assessment in Pulmonary Arterial Hypertension.Hongyang Pi, Samuel G Rayner, Ali Shojaie, Sina A Gharib, Peter J Leary
Circulation. Heart Failure. 2025-09-03 - Ambient Air Pollution Exposure and Mortality in the Pulmonary Hypertension Association Registry.Xinmei Huang, Aparna Balasubramanian, Jude Moutchia, Kayleen Williams, Nadine Al-Naamani
Annals of the American Thoracic Society. 2025-09-01 - 2 citationsEchocardiographic Parameters and Risk Prediction in Pulmonary Arterial Hypertension: Insights From the Redefining Pulmonary Hypertension Through Pulmonary Vascular Dis...Monica Mukherjee, Vivek P Jani, Ryan Osgueritchian, Hoda Mombeini, Aiden Abidov
Chest. 2025-08-01
Press Mentions
6-Part Special Podcast Series Aims to Raise Awareness of Meth-PAHSeptember 15th, 2025- Discover CircResFebruary 16th, 2023
- COVID Vaccine for Patient with Rare Disease? Best Guess Is YesJanuary 21st, 2021
- Join now to see all
Grant Support
- REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary HypertensionUNIVERSITY OF WASHINGTON2024–2028
- REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary HypertensionUNIVERSITY OF WASHINGTON2023–2028
- The Pulmonary Hypertension- Multi-Dimensional Omics to Characterize Right Heart Adaptation (PH-MOCHA) studyUNIVERSITY OF WASHINGTON2020–2025
Professional Memberships
- Member
- Member
- Pulmonary Hypertension Association - PHAMember
- Pulmonary Vascular Research Institute - PVRIMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
